Heparin-Binding (Fibroblast) Growth Factor/Receptor Gene Expression in the Prostate

  • Wallace L. McKeehan
  • Mikio Kan
  • Jinzhao Hou
  • Fen Wang
  • Pamela Adams
  • Per-Erik Mansson


Heparin-binding (fibroblast) growth factors (HBGF) play both autocrine and paracrine roles in growth of normal and tumor prostate epithelial and mesenchymal cells. In the rat, expression of HBGF-1 dominates in normal tissue and slow-growing Dunning prostate tumor tissues. Both HBGF-1 and HBGF-2 are expressed in fast-growing, malignant variants of the Dunning tumor. Expression of HBGF-1 occurs in young normal prostate epithelial cells and disappears with age. Slow-growing Dunning tumor mesenchymal cells, not epithelial cells, constitutively express HBGF-1. HBGF requirement and receptor phenotype is altered in tumor epithelial cells. In contrast to IGF-1 and the Elg/Bek/Cek gene product, a candidate HBGF receptor, neither HBGF-1 nor HBGF-2 expression in normal and tumor tissues increases during androgenstimulated growth. Flg/Bek/Cek is expressed in young prostates, during androgen-stimulated growth of adult prostate, constitutively in tumors, and appears limited to the stromal cell fraction of the slow-growing tumors. Expression is elevated in the fast-growing, highly malignant tumors. Normal and slow-growing tumor epithelial cells have receptor sites for HBGF that may differ from Flg/Bek/Cek. Similar to rat prostate tissue, HBGF-1 expression dominates in young human prostate tissue. However, both HBGF-1 and HBGF-2 mRNA as well as the Flg/Bek/Cek gene are detectable in adult human prostate tissue. These differences in rat and human tissue may reflect differences in the epithelial:stromal cell ratio in prostates of the two species.


Mesenchymal Cell Cholera Toxin Prostate Tissue Normal Prostate Tumor Epithelial Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    McKeehan, W.L., Adams, P.S., and Rosser, M.P. Modified nutrient medium MCDB 151, dermed growth factors, cholera toxin, pituitary factors, and horse serum support epithelial cell and suppress fibroblast proliferation in primary cultures of rat ventral prostate cells. In Vitro 18:87–91, 1982.PubMedCrossRefGoogle Scholar
  2. 2.
    McKeehan, W.L., Adams, P.S., and Rosser, M.P. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid, cholera toxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal prostate epithelial cells in serum-free, primary cell culture. Cancer Res. 44:1998–2010, 1984.PubMedGoogle Scholar
  3. 3.
    Chaproniere, D.M. and McKeehan, W.L. Serial culture of single prostatic epithelial cells in serum-free medium containing low calcium and a new growth factor from bovine brain. Cancer Res. 46:819–824, 1986.PubMedGoogle Scholar
  4. 4.
    McKeehan, W.L., Adams, P.S. and Fast, D. Different hormonal requirements for androgenindependent growth of normal and tumor epithelial cells from rat prostate. In Vitro cell. Devel. Biol. 23:147–152, 1987.CrossRefGoogle Scholar
  5. 5.
    McKeehan, W.L. and Adams, P.S. Heparin-binding growth factor / prostatropin attenuates inhibition by rat prostate tumor epithelial cell growth by transforming growth factor type beta. In Vitro Cell. Devel. Biol. 24:243–246, 1988.CrossRefGoogle Scholar
  6. 6.
    Mansson, P-E., Adams, P., Kan, M. and McKeehan, W.L. Heparinbinding growth factor gene expression and receptor characteristics in normal rat prostate and two transplantable rat prostate tumors. Cancer Res. 49:2485–2494, 1989.PubMedGoogle Scholar
  7. 7.
    Crabb, J.W., Armes, L.G., Carr, S.A., Johnson, C.M., Roberts, G.D., Bordoli, R.S. and McKeehan, W.L. The complete primary structure of prostatropin, a prostate epithelial cell growth factor. Biochemistry 25:4933–4988, 1986.CrossRefGoogle Scholar
  8. 8.
    McKeehan, W.L. and Crabb, J.W. Isolation and characterization of different molecular and chromatographic forms of heparin-binding growth factor 1 from bovine brain. Anal. Biochem. 164:563–569, 1987.PubMedCrossRefGoogle Scholar
  9. 9.
    Burgess, W.H. and Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Ann. Rev. Biochem. 58:575–606, 1989.PubMedCrossRefGoogle Scholar
  10. 10.
    Finch, P.W., Rubin, J.S., Miki, T., Ron, D. and Aaronson, S.A. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245:752–755, 1989.PubMedCrossRefGoogle Scholar
  11. 11.
    Kan, M., DiSorbo, D., Hou, J., Hoshi, H., Mansson, P.E. and McKeehan, W.L. High-and lowaffinity binding of heparin-binding growth factor to a 130 kD receptor correlates with stimulation and inhibition of growth of a differentiated human hepatoma cell. J. Biol. Chem. 263:11306–11313, 1988.PubMedGoogle Scholar
  12. 12.
    Murphy, L.J., Bell, G.I., Duckworth, M.L. and Friesen, H.G. Identification, characterization and regulation of a rat complementary deoxy-ribonucleic acid which encodes insulin-like growth factor-1. Endocrinology 121:684–691, 1987.PubMedCrossRefGoogle Scholar
  13. 13.
    Ruta, M., Howk, R., Ricca, G., Drohan, W., Zabelshansky, M., Laureys, G., Barton, D.E., Francke, U., Schlessinger, J., and Givol, D. A novel protein tyrosine kinase whose expression is modulated during endothelial cell differentiation. Oncogene 3:9–15, 1988.Google Scholar
  14. 14.
    Kornbluth, S., Paulson, K.E., and Hanafusa, H. Novel tyrosine kinase identified by phosphotyrosine antibody screening of cDNA libraries. Mol. Cell. Biol. 8:5541–5544, 1988.PubMedGoogle Scholar
  15. 15.
    Lee, P.L., Johnson, D.E., Cousens, L.S., Fried, V.A., and Williams, L.T. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science 245:57–60, 1989.PubMedCrossRefGoogle Scholar
  16. 16.
    Pasquale, E.B., and Singer, S.J. Identification of a developmentally regulated protein-tyrosine kinase by using anti-phosphotyrosine antibodies to screen a cDNA expression library. Proc. Natl. Acad. Sci. USA 86:5449–5453, 1989.PubMedCrossRefGoogle Scholar
  17. 17.
    Story, M.T., Sasse, J., Jacobs, S.C., and Lawson, R.K. Prostatic growth factor: purification and structural relationship to basic fibroblast growth factor. Biochemistry 26:3843–3849, 1987.PubMedCrossRefGoogle Scholar
  18. 18.
    Mydlo, J.H., Michaeli, J., Heston, W.D.W., and Fair, W.R. Expression of basic fibroblast factor mRNA in benign prostatic hyperplasia and prostatic carcinoma. The Prostate 13:241–247, 1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Cunha, G.R., Donjacour, A.A., Cooke, P.S., Mee, S., Bigsby, R.M., Higgins, S.J., and Sugimura, Y. The endocrinology and developmental biology of the prostate. Endocrine Rev. 8:338–362, 1987.CrossRefGoogle Scholar
  20. 20.
    Kan, M., Huang, J., Mansson, P.E., Yasumitsu, H., Carr, B., and McKeehan, W.L. Heparinbinding growth factor type 1 (acidic fibroblast growth factor): A potential biphasic autocrine and paracrine regulator of hepatocyte regeneration. Proc. Natl. Acad. Sci. USA 86:7432–7436, 1989.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Wallace L. McKeehan
    • 1
  • Mikio Kan
    • 1
  • Jinzhao Hou
    • 1
  • Fen Wang
    • 1
  • Pamela Adams
    • 1
  • Per-Erik Mansson
    • 1
  1. 1.W. Alton Jones Cell Science Center, Inc.Lake PlacidUSA

Personalised recommendations